BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 321690)

  • 1. Inhibition of polymorphonuclear leukocyte capping by a chemotactic factor.
    Mandell BF; Spilberg I; Lichtman J
    J Immunol; 1977 Apr; 118(4):1375-8. PubMed ID: 321690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphonuclear leukocytes cap a derivative of wheat germ agglutinin upon stimulation with formyl peptide and C5a but not leukotriene B4.
    Kurrasch R; Elfman F; Perez HD
    J Immunol; 1989 Sep; 143(6):1969-73. PubMed ID: 2550548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting the redistribution of surface-bound concanavalin A on human polymorphonuclear leukocytes.
    Ryan GB; Borysenko JZ; Karnovsky MJ
    J Cell Biol; 1974 Aug; 62(2):351-65. PubMed ID: 4426911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A proposed model for chemotactic deactivation: evidence for microtubule modulation of polymorphonuclear leukocyte chemotaxis.
    Spilberg I; Mandell B; Hoffstein S
    J Lab Clin Med; 1979 Aug; 94(2):361-9. PubMed ID: 458252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing extracellular potassium causes calcium-dependent shape change and facilitates concanavalin A capping in human neutrophils.
    Roberts RL; Mounessa NL; Gallin JI
    J Immunol; 1984 Apr; 132(4):2000-6. PubMed ID: 6699404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pentoxifylline on developmental changes in neutrophil cell surface mobility and membrane fluidity.
    Newton JA; Ashwood ER; Yang KD; Augustine NH; Hill HR
    J Cell Physiol; 1989 Sep; 140(3):427-31. PubMed ID: 2550471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification of the activity of human leukocyte inhibitory factor (LIF) by the generation of a low molecular weight inhibitor of PMN leukocyte chemotaxis.
    Goetzl EJ; Rocklin RE
    J Immunol; 1978 Sep; 121(3):891-6. PubMed ID: 690441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concanavalin a capping of rhesus monkey polymorphonuclear leukocytes.
    Cheung AT; Kimura GM; Miller ME; Walsh EM
    J Med Primatol; 1985; 14(5):285-9. PubMed ID: 4057241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concanavalin A cap formation on human polymorphonuclear leukocytes induced by R17934, a new antitumor drug that interferes with microtubule assembly.
    Oliver JM
    J Reticuloendothel Soc; 1976 Jun; 19(6):389-95. PubMed ID: 940091
    [No Abstract]   [Full Text] [Related]  

  • 10. Reduced concanavalin A capping of neonatal polymorphonuclear leukocytes (PMNs).
    Kimura GM; Miller ME; Leake RD; Raghunathan R; Cheung AT
    Pediatr Res; 1981 Sep; 15(9):1271-3. PubMed ID: 7290777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concanavalin A induces patching/capping of the platelet membrane glycoprotein IIb/IIIa complex.
    Kakaiya RM; Kiraly TL; Cable RG
    Thromb Haemost; 1988 Apr; 59(2):281-3. PubMed ID: 3388299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of inhibitors of cellular function on chemotactic factor-induced neutrophil aggregation.
    O'Flaherty JT; Kreutzer DL; Showell HJ; Ward PA
    J Immunol; 1977 Nov; 119(5):1751-6. PubMed ID: 915280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro effect of colchicine on neutrophil granulocyte locomotion. Assessment of the effect of colchicine on chemotaxis, chemokinesis and spontaneous motility, using a modified reversible Boyden chamber.
    Valerius NH
    Acta Pathol Microbiol Scand B; 1978 Jun; 86B(3):149-54. PubMed ID: 716916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rearrangement of Con A and WGA receptors on murine mastocytoma cell membranes: relationship to cell cycle.
    Lustig S; Pluznik DH
    J Cell Physiol; 1983 Apr; 115(1):87-92. PubMed ID: 6403559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of lymphocytes in the neutrophil migration induced by ovalbumin in immunized rats.
    Klein A; Cunha FQ; Ferreira SH
    Immunology; 1995 Apr; 84(4):577-84. PubMed ID: 7540591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human lymphocyte surface immunoglobulin capping. Normal characteristics and anomalous behavior of chronic lymphocytic leukemic lymphocytes.
    Cohen HJ
    J Clin Invest; 1975 Jan; 55(1):84-93. PubMed ID: 1088910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organophosphorus inhibition of lysosomal enzyme secretion from polymorphonuclear leucocytes. Evidence of a lack of a requirement for esterase activation.
    Becker EL; Koza EP; Sigman M
    Immunology; 1978 Aug; 35(2):373-80. PubMed ID: 750374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotaxis of human leucocytes: II. Effects of lectins, colchicine, cytochalasin B, cyclic nucleotides and immuno-stimulatory products.
    Pham Huu T
    Biomedicine; 1979 Jun; 30(2):121-4. PubMed ID: 224965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of a pertussis toxin substrate in the control of lectin-induced cap formation in human neutrophils.
    Lad PM; Olson CV; Grewal IS
    Biochem J; 1986 Aug; 238(1):29-36. PubMed ID: 3026344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in concanavalin A cap formation on lymphoma cells following interaction with inactive influenza viruses.
    Weil-Hillman G; Levi R; Zakay-Rones Z
    Acta Virol; 1991 May; 35(3):238-46. PubMed ID: 1683129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.